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Abstract 
Electromagnetic radiation (photons) or particle beam (protons or heavy ions) 
have similar biological effects, i.e. damage to human cell DNA that eventually 
leads to cell death if not correctly repaired. The biological effects at the level 
of organs or organisms are explained by a progressive depletion of 
constitutive cells; below a given threshold, cell division is no longer sufficient 
to compensate for cell loss, up to a point where the entire organism (or organ) 
breaks down. The quantitative aspects of the biological effects are modulated 
by the microscopic distribution of energy deposits along the beam or particle 
tracks. In particular, the ionization density, i.e. the amount of energy deposited 
by unit path length (measured in keV/μm), has an influence on the biological 
effectiveness, i.e. the amount of damage per energy unit deposited (measured 
in gray or Gy, equivalent to 1 joule/kg). The ionization density is usually 
represented by the Linear Energy Transfer or LET, also expressed in keV/μm. 
Photon beams (X-rays, g-rays) are low-LET radiation, with a sparsely ionising 
characteristic. Particle beams have a higher LET, with a more dense 
distribution of energy deposits along the particle tracks. Protons are 
intermediary, with a LET larger than the photon one, but still belong to the 
‘radiobiological’ group of low LET. The higher the ionization density, the 
higher the biological effectiveness per unit of dose. When comparing various 
radiation qualities, it appears that the ionization density is relatively 
homogeneous along photon tracks, whereas it strongly varies along particular 
tracks (protons, heavy ions). In the first instance, the biological effectiveness 
is proportional to the TEL, itself dependant on the particle beam energy. So, 
when the LET of a particle beam is increased, its biological effectiveness 
increases in proportion. Secondly, a low-energy beam (f.i. 4 MeV a rays) has 
a higher LET than a high-energy beam (f.i. 200 MeV a rays). As particle 
beams continuously loose their energy through their successive interactions 
with the irradiated medium, it ensues that the LET slowly increases along the 
beam path, down to a point where all energy has been imparted and the beam 
stops. Therefore, the biological effectiveness is not homogeneous along the 
beam path (like with low-LET radiation), with a strong reinforcement at the 
end of the particle tracks (in the Bragg peak). The modelization of the clinical 
effects of particle beams is therefore very challenging, as a variable biological 
weighting function needs to be incorporated in the planning process to account 
for the increase in biological effectiveness with the progressive loss of beam 
energy. 
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1 Introduction 
The performance of radiotherapy can be improved in two separate ways: (a) improvement of the ballistic 
selectivity (increasing the dose to the tumour while reducing the exposure of normal tissue) and (b) 
improvement of the biological effectiveness of the radiation (using radiation with a higher relative 
biological effectiveness, RBE). Clinical proton beams are ballistically superior but biologically 
equivalent to X-rays (and gamma rays), while carbon-ion beams are both ballistically and biologically 
more efficient than X-rays. 
From the biological point of view, the effect of radiation on living material is mainly due to DNA 
damage and its consequences: DNA disruption, loss of genetic information, incapacitation of vital genes, 
and, eventually, cell death. Indeed, severe DNA damage rapidly induces cell apoptosis (a sophisticated 
mechanism of auto-destruction) if the DNA is not correctly repaired in time (a few hours). It may, 
however, happen that some cells manage to survive despite severe DNA damage, but they often do so 
with some amount of ‘misrepair’, i.e., incorrectly repaired DNA damage with a change in the 
information sequence (gene inactivation, gene promotion, etc.). 
Cells that survive severe DNA damage are rare, but can be dangerous if they harbour gene 
alterations that may lead to cancer (loss of proliferation regulation, loss of apoptosis, and tissue invasion 
and colonization). 
The sequence of events leading to cell death can be summarized in the following way: 
– Energy is deposited in DNA (by primary and secondary electrons) along radiation tracks, in 
consecutive ionization events. In fact, what happens is an ‘exchange’ of energy between the 
radiation and peripheral electrons of the atoms constituting the DNA, causing electrons to break 
loose from atoms and collide further with other, neighbouring atoms. Often, a cluster of 
ionization arises from the accumulation of the primary energy exchange event and the 
interactions of secondary electrons. 
– The appearance of positive charges in the DNA molecule causes a rearrangement or, worse, a 
complete disruption of the molecular structure if the energy imparted exceeds the binding 
energy of the atoms. The sequence of information coded in the DNA strands is therefore 
interrupted by a break. 
– DNA rearrangement follows detection of damage. This process is amazingly fast: induction of 
repair enzymes starts within minutes after DNA damage. 
– Repair induction (enzyme synthesis) occurs in proportion to the amount of damage, though only 
up to a certain point, as massive damage tends to saturate the repair mechanisms. Repair usually 
takes 4 to 6 hours. Slight damage can be repaired faster; severe damage takes longer. Owing to 
the dual structure of DNA, i.e., a structure of two long strands that mirror each other, a single-
strand break is easily repaired, but a double-strand break is not. The repair mechanisms excise 
damaged DNA sequences and rebuild intact DNA by reading the ‘mirror’ strand. If both strands 
are damaged, the danger of a faulty repair (misrepair), i.e., a repair resulting in DNA with 
modified information, is larger. 
– The cell cycle is arrested at the same time as repair induction, in order to ‘lend’ sufficient time 
for repair before the next cell division is triggered. 
– Along with DNA repair, apoptosis is also triggered. This might look illogical but, in fact, it is a 
strong protective mechanism against misrepair. Apoptosis is a stepwise process, each step being 
reversible up to a certain ‘no-return’ point at which the process becomes unstoppable. This point 
is reached after a definite time period. If at that point the repair is not finished (because the 
damage is too dense), then apoptosis proceeds until cell death. Conversely, if the repair is 
finished before that point (because the damage is limited), then apoptosis is stopped and the cell 
survives. How does this mechanism protect cells? In fact, it does not protect individual cells, 
but it protects the information conveyed by a cell population, by eliminating severely damaged 
cells that are at risk of misrepair and corruption of the information in the DNA.1 
– The cell dies (as a result of apoptosis or misrepair) or survives (with either adequate or 
inadequate DNA repair). 
– Tissue failure (in the case of normal tissue) occurs if enough cells have been destroyed, or cancer 
cure is achieved (in the case of cancer) if all cancer cells have been destroyed. 
2 Density of ionization and microdosimetry 
Whether the damage to DNA is light or severe depends in the first instance on the amount of energy 
dissipated in the molecule (the ‘dose’), but it also depends on the density of ionizing tracks crossing the 
molecule. A few dense tracks are biologically more effective than several sparsely ionizing tracks. 
Therefore, smaller doses with ‘dense’ tracks are as effective in killing cells as larger doses with less 
dense tracks. 
This density is related to the amount of energy per unit track length and to the distance between 
consecutive energy deposition events along the track of the particle (a photon in the case of X-rays, or 
a proton or carbon ion in hadron therapy); more specifically, it is related to the number of energy 
deposition or ionization events that occur in the short diameter of the DNA (a few nanometres). Densely 
ionizing radiation usually deposits enough energy to inactivate a cell in one single track, whereas 
sparsely ionizing radiation requires the cooperation of several tracks, each depositing a small amount of 
energy insufficient to kill a cell, to achieve the same result (Fig. 1). 
 
Fig. 1: Schematic representation of particle tracks for low-LET (left) and high-LET (right) radiation [1, 2]. For 
low-LET radiation, the inactivation of a radiosensitive target requires the conjunction of several tracks, whereas 
for high-LET radiation the impact of a single track is always fatal (closed circles). 
The linear energy transfer (LET), a quantity expressed in keV/μm of particle track, measures the 
density of ionization per unit length along radiation tracks. Types of radiation can be sorted by their 
LET, with a customary distinction between low-LET (<10–20 keV/μm) and high-LET (>20 keV/μm) 
radiation. 
Energy deposition in DNA is a quantized or random event, sometimes important, sometimes not. 
But the maximum energy that can be imparted in a single interaction depends directly on the LET. Low-
LET radiation therefore very seldom kills cells with a ‘single hit’, whereas this is very common with 
high-LET radiation. 
                                                     
1 This explains why embryos exposed to radiation most often do not survive. Indeed, inheritable DNA mutations have not 
been observed in the Hiroshima and Nagasaki survivors. 
One particular dosimetric method allows individual energy deposition events to be measured in 
the eV range. This method is called ‘microdosimetry’, as its purpose is to describe energy exchange at 
the molecular level. In short, the overall concept is to miniaturize a dosimeter and to expose it to an 
extremely low particle fluence in order to register interactions separately. These interactions are 
measured by collecting electric charges created in a counter whose volume is artificially reduced by 
lowering the gas pressure in the measurement chamber. A very low pressure of a tissue-equivalent gas 
mimics a very small volume at normal atmospheric pressure, in the range of cubic micrometres. 
Nowadays, most microdosimetry is no longer done physically but done ‘in silico’ using Monte Carlo 
simulation methods. 
Irradiating at low fluence and integrating all energy deposition events in a single graph yields a 
‘microdosimetric spectrum’ specific to the radiation or particle type tested (Fig. 2). Small variations in 
the particle energy are reflected in small variations in the microdosimetric spectrum. In turn, variations 
in the microdosimetric spectrum illustrate differences in biological effectiveness, i.e., in the proportion 
of cells irreversibly damaged when it comes to cell kill. 
 
Fig. 2: Comparison of microdosimetric spectra of y.d(y) vs. y obtained for cobalt-60 gamma rays, 65 MeV protons, 
and p(65) + Be neutrons [3]; y is the lineal energy and d(y) is the probability density of the absorbed dose with 
respect to y. For cobalt-60 gamma rays, the maximum y.d(y) values occur at about 0.3 keV/μm. For protons and 
neutrons, the maxima are observed at about 3 keV/μm and 10 keV/μm, respectively. 
3 Relative biological effectiveness 
Again, minute energy deposition events are unable to damage DNA in a significant manner, whereas 
massive energy deposition events invariably kill the cell. When different types of radiation are compared 
(e.g., X-rays, neutrons, and alpha particles), the relationship between dose and cell survival shows that 
for the same amount of energy dissipated (i.e., the same radiation dose), the number of cells killed 
increases with the LET (Fig. 3). 
 
Fig. 3: Survival curves for cells exposed to radiation of different LET. The slopes of the curves become steeper as 
the LET of the radiation increases. The bending of the curves (i.e., the initial shoulder) is also progressively 
reduced. (Redrawn from Ref. [4].) 
Conversely, for an identical cell kill level (known as an isoeffect), the dose required decreases as 
the LET increases. The ratio of the low-LET dose to the high-LET dose required for an isoeffect is 
called the RBE. It tends to increase with LET up to a maximum value, depending on the isoeffect 
considered (Fig. 5). Above this maximum value, the RBE decreases as the ionization density becomes 
very large, and most of the energy is wasted (an overkill phenomenon). 
The RBE is a dimensionless quantity (as it is a ratio of doses) that compares the biological 
effectiveness of a given type of radiation with another type taken as a reference, usually cobalt-60 
gamma rays. Thus, when cobalt-60 radiation is compared with itself, the RBE is 1. Up to an LET of 
around 20 keV/μm, the RBE remains stable at 1. Above this LET value, the RBE increases rapidly to a 
maximum value at around 100 keV/μm. 
RBE values depend on the isoeffect level chosen for the comparison of radiation beams. Small 
radiation doses tend to increase the RBE, since at low doses, low-LET radiation is very ineffective in 
killing cells, whereas high-LET radiation is quite effective in doing so. At higher doses, low-LET 
radiation becomes more lethal and the difference in effect between low- and high-LET radiation 
becomes smaller. At very high doses, the RBE reaches a stable value that no longer depends on the dose 
(Fig. 4). The RBE also depends on the biological system under consideration. 
 
Fig. 4: Survival curves for intestinal crypt cells irradiated with neutrons or cobalt-60 gamma rays. The RBE is 
particularly variable in the initial part of the curves (i.e., for small doses), where it reaches its highest value. This 
variation is mainly due to the bending (i.e., the shoulder) of the gamma-ray curve. As the dose increases, the RBE 
stabilizes progressively, tending towards a minimum. 
4 Time factor and repair 
So, it is the spatial structure of the ionization events that characterizes the various types of radiation 
beams. If dense ionization crosses DNA, it will invariably destroy it beyond any possibility of repair. 
Too much information is lost in the event. Carbon-ion beams belong to the class of radiation that causes 
such dense ionization, i.e., high-LET radiation. 
Low-LET radiation, conversely, only kills cells by the cooperation of several tracks that occur 
together spatially and in time: spatially to ‘build up’ damage at a particular molecular site, and in time 
because consecutive ‘hits’ must occur before the previous ‘hit’ has been repaired. For this reason, 
lowering the dose rate of the irradiation sharply decreases the biological effectiveness, as more time is 
available for the repair of damage before the next ionization takes place. Conversely, lowering the dose 
rate with high-LET radiation does not alter the biological effectiveness much, since a single hit is 
sufficient to inactivate a cell. 
Another way to decrease the biological effectiveness of low-LET radiation is to deliver the dose 
in several small fractions, separated by sufficient time for DNA repair. In this case, spatial cooperation 
does not work, since small amounts of DNA damage are repaired between consecutive fractions. The 
longer the time between fractions, the more thorough the repair of the DNA. Again, this does not 
influence the biological effectiveness of high-LET radiation, as one single hit in the DNA is usually 
sufficient to kill the cell, without the need for spatial cooperation. 
5 The effect of oxygen 
It was observed early in the history of radiobiology that the radiosensitivity of cells depends on the 
partial pressure of oxygen in the immediate environment. When oxygen is present at normal atmospheric 
concentration, the radiosensitivity is at its highest. Lowering the partial pressure of oxygen progressively 
decreases the radiosensitivity, by a factor of that reaches 3 when oxygen is absent (or nearly absent) 
(Fig. 5). 
 
Fig. 5: Comparison of the influence of partial pressure of oxygen for radiation with different LETs. OER (Oxygen 
Enhancement Ratio) equals 3 for low-LET radiation; this value seems to be independent of the dose level and, to 
a certain extent, of the biological system. The OER value is thus commonly interpreted as a ‘scale factor’. The 
OER value decreases as the LET increases, down to 1 for very high-LET particles. Redrawn from Refs. [4, 5]. 
Obviously, no aerobic cell (as are human cells f.i.) is viable for more than a few minutes without 
any oxygen supply. But at a low partial pressure, some survival, often in a quiescent state, remains 
possible for hypoxic cells, which can then escape the effect of radiation doses that would otherwise be 
lethal. 
In oncology, the blood supply of cancerous masses is commonly deficient, and large regions of 
hypoxia exist in virtually all tumours. This has proven to be a problem of importance in radiotherapy, 
and ways to overcome hypoxic radioresistance have been developed (see Section 7). 
Oxygen can thus be considered as a ‘natural’ radiosensitizer. Without entering too much into 
details, we can say that the presence of oxygen ‘fixes’ damage in the DNA. What actually happens is 
that with low-LET radiation, most of the damage is absorbed by water, in the close vicinity of the DNA 
molecule. In physics terms, the DNA itself has a very small ‘cross-section’ for X-rays, and most of the 
damage to it is created by radiolysis of water, which creates free radicals, which in turn interact 
secondarily with the DNA molecule. The life-span of these free radicals and their ability to migrate 
some distance is influenced by the presence or absence of oxygen. It is said that oxygen is needed to 
‘fix’ the damage (‘fix’ in the sense of fixation, not of repair). In its absence, the free radicals are less 
toxic to the DNA. 
This influence of the partial pressure of oxygen is at its highest with low-LET radiation. As the 
LET of the radiation is progressively increased above 20 keV/μm, the sensitizing effect of oxygen 
progressively disappears because DNA damage is now usually the consequence of a direct, very dense 
hit on the molecule, whose fixation no longer requires the presence of oxygen. This is what makes 
carbon-ion beams clinically so attractive, since their LET is in the range where no oxygen is required to 
‘fix’ the lethal DNA damage. Indeed, carbon ion therapy is advocated for the treatment of cancer types 
in which a large hypoxic component is suspected. 
6 Cell cycle and cell division 
Cell division is a lengthy and subtle process in which the cell duplicates its DNA before starting to 
physically divide. The structure of DNA allows this process to be precise and fail-safe (indeed, this is a 
condition for life). By duplicating each of the two strands constituting the DNA molecule, the cell 
doubles its set of chromosomes. The two sets then migrate in opposite directions, and the cell is cleaved 
between them. 
DNA synthesis relies on a set of specific enzymes that ‘gently’ separate the two DNA strands and 
synthesize a new copy on each of them. The end result is two identical DNA molecules. The same 
enzymes are mobilized in the case of accidental DNA damage during the lifetime of a cell; they excise 
the damaged DNA section and then resynthesize the missing part of the DNA, using the other strand as 
a template for the exact restitution of the coded information. 
The synthesis and repair enzymes normally have a very low concentration in the nucleus, at times 
not close to cell division. But any damage will trigger enzyme synthesis (in a matter of minutes) in order 
for repair to proceed efficiently. 
Conversely, during cell division, the DNA synthesis enzymes are at their maximum concentration 
in the nucleus. If radiation damage is inflicted during cell division, the cell tends to be more resistant as 
the nucleus is already saturated with all of the enzymes needed for repair, especially at the end of DNA 
synthesis, when the enzymes are no longer required for duplication and therefore are free for binding to 
any new substrate (damaged DNA, for instance). When DNA synthesis is finished, the cell remains 
quiescent for some time (called the G2 phase), just before physically dividing. At that point the cell is 
at its most vulnerable to radiation damage, since repair is less effective in the presence of all the 
rearrangement needed for cell division. 
The variation in the sensitivity of cells with the division cycle is more pronounced with low-LET 
radiation, quite logically, since repair plays an important role in the end result of radiation exposure. In 
contrast, the sensitivity to high-LET radiation damage is independent of the cell cycle, since repair plays 
no or only a very minor role in the end result (Fig. 6). 
 
Fig. 6: Left panel: survival curves for cells irradiated in different phases of their mitotic cycle. Right panel: 
variation of the slope of the curves (the parameter α) as a function of LET. The gap between the slopes of the 
various curves (i.e., the difference in radiosensitivity) gradually becomes smaller as the LET increases. 
7 Biological weighting function 
The preceding considerations about the variations of radiosensitivity and the biological effectiveness of 
low- and high-LET radiation find quantitative expression in the so-called Biological Weighting Function 
(BWF), which is obtained by plotting the RBE against the LET (Fig. 7) [6, 7]. BWFs are specific to a 
given biological effect and given irradiation conditions, so that the peak value (the maximum of the 
RBE) and its place in the LET range may vary substantially. The main sources of variation are the dose 
and the oxygenation status of the biological material: the RBE of high-LET radiation with respect to 
cobalt-60 gamma rays increases as the dose decreases and when the partial pressure of oxygen decreases. 
Recall here that the higher RBE of carbon ions for hypoxic cells with respect to normally oxygenated 
cells is one of the main justifications for using these particles in radiotherapy. 
 
 
Fig. 7: Top: microdosimetric spectra for a 90 MeV energy-modulated proton beam. Measurements at four 
positions are shown (solid lines). These are compared with cobalt-60 gamma rays (dotted line). The BWF for 
different LET values has been superimposed (bold dotted line). The proton microdosimetric spectra are shifted 
towards higher LET values when measured more distally in the SOBP (Spread Out Bragg Peak - bold solid lines). 
This suggests that the proton RBE would also increase with depth. Bottom: dose–effect relationships for crypt 
regeneration in mice after irradiation in a single fraction with a 200 MeV energy-modulated proton beam at 
iThemba Labs, South Africa. The beam was modulated to produce a 7 cm SOBP. The open and closed circles 
correspond to irradiation in the middle and at the end of the SOBP, respectively (see the sketch of the dose profile 
at the top of the panel). Each point is the average of the readings for four mice. Parallel exponential regression 
curves were fitted through the points by a weighted least squares method. The error bars correspond to the 95% 
confidence intervals. In the case shown here, the RBE increases by 9% on moving from the middle to the end of 
the SOBP. 
8 Proton beams 
The RBE of protons is just above unity, usually around 1.1–1.15, indicating that the fractionation effect 
still matters with this type of radiation. Proton beams are a characteristic low-LET radiation. 
A more precise examination of their microdosimetric spectrum, however, shows that small 
variations in LET can be observed along the particle paths. At the entrance to the irradiated medium, 
high-energy protons are sparsely ionizing, and thus typically low-LET. When they are close to the end 
of their path, at the place where all the remaining kinetic energy will be released (the Bragg peak), the 
LET increases sharply, though by only a modest amount. But this small change is sufficient to modify 
the RBE. Therefore, the RBE is not constant over the entire proton path. 
The explanation is quite simple: as the protons enter the medium and penetrate deeper and deeper, 
they progressively release some of their kinetic energy and slow down, until they reach the end of their 
path. As the speed decreases, the distance between consecutive energy deposition events also decreases; 
hence, the LET increases, and the RBE increases in turn. Proton beams thus do not have a constant 
biological effectiveness along their path. But, again, the variation in RBE remains modest. 
Precise radiobiological experiments with mice, using a model of intestinal toxicity, have been 
able to measure these RBE variations at the end of the proton path, by repeating measurements across 
the small distance covering the end of an extended Bragg peak. Radiobiological data demonstrate that 
the RBE indeed varies, and in the proportions predicted by the microdosimetric shift in LET. 
9 Carbon-ion beams 
The physics of carbon-ion beams is similar to that of proton beams (a plateau at the entrance point of 
the beam, followed by a sharp rise in dose at the end of the path, at the Bragg peak), but the mass of 
carbon ions is much greater. Therefore, carbon-ion beams are high-LET along their entire path, though 
with a similar pattern to that of protons: the LET is lower near the entrance point of the beam and at its 
highest at the Bragg peak. 
The range of the RBE is close to 2–3 at the Bragg peak, and closer to 1.5–2 at the entrance point. 
The variation of the RBE along the path of a carbon ion is therefore much larger than for protons, which 
calls for some adjustment when irradiating under clinical conditions. 
Usually, when a tumour is irradiated with X-rays or gamma rays (low-LET radiation), a 
homogeneous level of dose is delivered to the entire volume, with the intention of delivering an 
‘isoeffect’ to the tumour. No specific attention to the size of the tumour is needed, as the biological 
effectiveness of low-LET radiation remains the same across the entire irradiated volume (RBE = 1). 
This is not the case with carbon-ion beams, since the biological effectiveness increases 
significantly within the irradiated volume. If a homogeneous ‘biological’ dose is planned throughout the 
tumour volume, then some alteration to the ‘physical’ dose needs to be made, to compensate for the 
variation in RBE [8]. Precise measurements that illustrate this variation in RBE have been done with 
the clinical carbon-ion beam at HIMAC (Fig. 8). 
  
 
Fig. 8: Left panel: dose–effect relationships for intestinal crypt regeneration in mice after irradiation with cobalt-
60 gamma rays or carbon-12 ions at the entrance plateau and at different positions in a 6 cm SOBP (the positions 
are shown in the sketch in the right panel). Right panel: the corresponding RBEs (reference cobalt-60 gamma 
rays), plotted against the depth, indicate a substantial increase in the RBE. As the irradiations were performed with 
single high doses, these RBEs are much lower than those for fractionated irradiations, which reach a value of 
approximately 3 at the end of the SOBP. 
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